Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold 10,683 shares at $11.14 ($121K) on 2015-08-20, disclosed to the SEC on 2015-08-20.
Open-market sale of $121k TCON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.40 | 9,000 | $103K | 84.5% |
| 2 | $11.14 | 1,683 | $19K | 15.5% |
| Total | $11.36 avg | 10,683 | $121K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |